Robert F. Kennedy Jr. Plans to Continue Earning from Vaccine Litigation Amid HHS Secretary Nomination

Robert F. Kennedy Jr., HHS Secretary nominee, aims to maintain financial ties to litigation against Merck despite potential conflicts of interest.

c 67%

r 33%

RFK Jr. plans to keep a financial stake in lawsuits against the drugmaker Merck

NPR

RFK Jr. says he's resigned from anti-vaccine nonprofit as he seeks nation's top health official job

Associated Press

RFK Jr. releases financial disclosure

The Hill

RFK Jr. Financial Disclosure Shows Contingent Law Firm Fees

Newsmax

RFK Jr. Financial Disclosure Shows Contingent Law Firm Fees

Newsmax

RFK Jr. earned millions from law work, book deals

Axios

Subscribe to unlock this story

We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!

Get Started

Have an account? Sign in

Overview

A summary of the key points of this story verified across multiple sources.

Robert F. Kennedy Jr., nominated as HHS Secretary by President Trump, seeks to continue collecting fees from Wisner Baum, a law firm suing Merck over the Gardasil vaccine. This decision raises ethics concerns due to his ongoing financial interest in vaccine-related lawsuits while regulating the pharmaceutical industry, prompting scrutiny in his upcoming Senate confirmation hearing. Kennedy disclosed significant earnings, including $856,559 from the law firm, and plans to divest from other investments, but intends to keep a role in non-U.S. related cases.

Written by AI using shared reports from

6 articles

Report issue